Literature DB >> 2816508

Interleukin-6 is produced by bone and modulated by parathyroid hormone.

J H Feyen1, P Elford, F E Di Padova, U Trechsel.   

Abstract

Interleukin-6 (IL-6) is a cellular regulatory molecule, the diverse functions of which relate to cells both within and outside the immune system. In this report we demonstrated that bone tissue, specifically osteoblasts, produce interleukin-6 and that this function can be modulated by the osteotrophic hormone parathyroid hormone (PTH). Given that the complex process of bone remodeling is now thought to be regulated not only by systemic hormones but also by locally produced factors, the existence of a parathyroid hormone-stimulated production of interleukin-6 by osteoblasts may have important physiological significance.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2816508     DOI: 10.1002/jbmr.5650040422

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  32 in total

1.  On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion.

Authors:  A Ray; K S LaForge; P B Sehgal
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

2.  Hemopoietic functions of marrow-derived osteogenic cells.

Authors:  D Benayahu; M Horowitz; D Zipori; S Wientroub
Journal:  Calcif Tissue Int       Date:  1992-09       Impact factor: 4.333

3.  Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow.

Authors:  S C Lin; T Yamate; Y Taguchi; V Z Borba; G Girasole; C A O'Brien; T Bellido; E Abe; S C Manolagas
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

Review 4.  Osteoblast responses to bacterial pathogens: a previously unappreciated role for bone-forming cells in host defense and disease progression.

Authors:  Ian Marriott
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

5.  Cytokines, hematopoiesis, osteoclastogenesis, and estrogens.

Authors:  S C Manolagas; R L Jilka
Journal:  Calcif Tissue Int       Date:  1992-03       Impact factor: 4.333

6.  Interleukin 6 is autoregulated by transcriptional mechanisms in cultures of rat osteoblastic cells.

Authors:  N Franchimont; S Rydziel; E Canalis
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

Review 7.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

8.  Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.

Authors:  G D Roodman; N Kurihara; Y Ohsaki; A Kukita; D Hosking; A Demulder; J F Smith; F R Singer
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

9.  17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens.

Authors:  G Girasole; R L Jilka; G Passeri; S Boswell; G Boder; D C Williams; S C Manolagas
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

10.  Interleukin-6 attenuates agonist-mediated calcium mobilization in murine osteoblastic cells.

Authors:  J Green; S Schotland; Z Sella; C R Kleeman
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.